JYNTNasdaqPatent Owners & LessorsFiscal year ends December 31
JOINT Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$7.27+0.24 (+3.41%)
Close on Oct 19, 2026
- Market cap
- $103.58M
- P/E (TTM)
- 26.9
- Dividend yield
- –
JOINT Corp revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Operations | $15.18M | $14.82M | $15.17M | $13.38M | $13.27M | $13.08M | $14.71M | $12.65M | $12.61M | $12.18M | $12.71M | $11.59M | 100.0% | +14.4% |
| Corporate clinics | – | – | – | – | – | – | – | $17.54M | $17.65M | $17.54M | $17.91M | $17.88M | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Franchise Operations | – | – | – | – | – | – | – | $5.59M | $3.94M | $5.34M | $6.42M | $5.14M | – |
| Corporate clinics | – | – | – | – | – | – | – | -$2.72M | -$248.92K | $1.49M | -$1.17M | -$931.37K | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Royalty fees | $8.33M | $8.03M | $8.89M | $8.11M | $8.13M | $8.07M | $8.84M | $7.87M | $7.85M | $7.59M | $7.98M | $7.14M | 54.9% | +2.4% |
| Advertising fund revenue | $3.72M | $3.65M | $3.47M | $2.34M | $2.33M | $2.31M | $2.53M | $2.25M | $2.24M | $2.17M | $2.28M | $2.05M | 24.5% | +59.3% |
| Software fees | $1.55M | $1.53M | $1.55M | $1.55M | $1.48M | $1.46M | $1.45M | $1.43M | $1.42M | $1.39M | $1.34M | $1.30M | 10.2% | +4.4% |
| Other revenues | $840.61K | $460.89K | $449.42K | $418.81K | $554.69K | $408.62K | $968.71K | $407.69K | $388.73K | $388.05K | $409.04K | $342.14K | 5.5% | +51.5% |
| Franchise and regional developer | $750.59K | $1.15M | $810.09K | $964.80K | $768.10K | $828.52K | $925.19K | $697.69K | $719.10K | $655.87K | $703.07K | $754.03K | 4.9% | -2.3% |
| Company clinics | – | – | – | – | – | – | – | $17.54M | $17.65M | $17.54M | $17.91M | $17.88M | – | – |
By region
From the segment and revenue-disaggregation notes of Joint's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.